Research Support

Current Research Support

CDC (U01 IP001184), “Evaluating respiratory virus vaccine effectiveness” (2022-2027).  Williams, Co-Investigator

NIH/NIAID (R01 AI085062), “Host determinants of human metapneumovirus immunity and pathogenesis” (2010-2027).  Williams, PI

NIH/NIAID (R21 AI180460), “Discovery of human metapneumovirus epitopes” (2024-2026).  Williams, PI

CDC (U01 IP001052), “New vaccine surveillance network” (2021-2026).  Williams, PI

CDC (U01 IP001141), “Agent based simulation of seasonal and pandemic influenza” (2020-2025).  Williams, PI

Completed Research Support

Merck, “SARS-CoV-2 surveillance in child care centers” (2021-2023).  Williams, Co-Investigator

CDC (75 D30121 C12246), “Development of innovative methods, tools, and strategies to evaluate effectiveness of vaccines in preventing outpatient, laboratory confirmed illness” (2021-2022).  Williams, Co-Investigator

CDC (U01 IP000035), “Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network” (2021-2022).  Williams, Co-Investigator

NIH/NHLBI (R33 HL137077), “Impact of virome on microbial communities in the respiratory tract” (2017-2022).  Williams, Co-Investigator

CDC (U01 IP001051), “New vaccine surveillance network” (2016-2021).  Williams, PI

CDC (U01 IP00046769), “Flu vaccine effectiveness in those hospitalized in a large diverse health system” (2016-2021).  Williams, Co-Investigator

NIH/NHLBI (R61 HL137077), “Impact of virome on microbial communities in the respiratory tract” (2017-2019).  Williams, Co-Investigator

NIH/NIAID (R21 AI107145), “High-throughput screening for inhibitors of human metapneumovirus” (2013-2016).  Williams, PI

CDC (U01 IP000467), “Influenza surveillance and vaccine effectiveness” (2011-2016).  Williams, Co-Investigator

CDC (U01 IP000464), “Enhanced surveillance for new vaccine preventable disease” (2011-2015).  Williams, Co-Investigator

NIH/NIAID (R01 AI085062), “Host determinants of human metapneumovirus immunity and pathogenesis” (2011-2015).  Williams, PI

Thrasher Research Fund, “The role of influenza virus and S. pneumoniae coinfection in severe-acute respiratory infections in young children” (2011-2013).  Williams, Co-Investigator

UBS Foundation, “Respiratory viral infection and vitamin D in Jordanian infants” (2010-2013).  Williams, Co-Investigator

Bill and Melinda Gates Foundation, “Burden of severe RSV lung disease in infants and young children” (2010-2013).  Williams, Co-Investigator

NIH/NIAID (R01 AI072414), “The human antibody response to metapneumovirus: Prophylaxis and vaccine
design” (2009-2012).  Williams, Co-PI

NIH/NIAID (R21 AI082417), “Attenuated strains of human metapneumovirus for vaccines and pathogenesis” (2009-2011).  Williams, PI

NIH/NIAID (R21 AI073697), “Cell entry of human metapneumovirus” (2008-2011).  Williams, PI

CDC (U18 IP000184), “Annual estimates of influenza vaccine effectiveness: Davidson County, TN” (2008-2011).  Williams, Co-Investigator

CDC (U01 IP00022), “Enhanced surveillance for newly vaccine preventable diseases” (2005-2011).  Williams, Co-Investigator

Binax Corporation, “Molecular viral diagnostics study” (2008-2009).  Williams, PI

MedImmune, “Evaluation of the prevalence of PIV3 associated respiratory tract infection in children” (2008-2009).  Williams, PI

NIH/NIAID (R03 AI068069), “Epidemiology and clinical features of human coronavirus” (2007-2009), Williams, PI

Protein Sciences Corporation, “Influenza vaccine trial laboratory evaluation” (2007-2009).  Williams, PI

Quidel, “Molecular diagnosis of influenza and RSV” (2006-2009).  Williams, PI

Vanderbilt University (Turner-Hazinski Award), “Candidate DNA and protein vaccines for human metapneumovirus in a cotton rat model” (2005-2007).  Williams, PI

NIH/NIAID (K08 AI56170), “Determinants of protective immunity to human metapneumovirus” (2003-2006).  Williams, PI

NIH/NIAID (R03 AI054790), “Human metapneumovirus infections in children” (2003-2005).  Williams, PI

NIH/NIAID (N01 AI25462), “Serological response to recombinant avian influenza H5 protein in recipients of
inactivated H5 vaccine subcontract protocol # 06-0014” (2003-2005).  Williams, PI

IDSA, “Ontogeny of the neonatal immune response to RSV” (2000-2002).  Williams, PI